Wayne Godfrey
2021
In 2021, Wayne Godfrey earned a total compensation of $4.3M as Chief Medical Officer at Janux Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $102,818 |
|---|---|
| Option Awards | $3,918,086 |
| Salary | $257,045 |
| Total | $4,277,949 |
Godfrey received $3.9M in option awards, accounting for 92% of the total pay in 2021.
Godfrey also received $102.8K in non-equity incentive plan and $257K in salary.
Rankings
In 2021, Wayne Godfrey's compensation ranked 3,108th out of 12,415 executives tracked by ExecPay. In other words, Godfrey earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,108 out of 12,415 | 75th |
Division Manufacturing | 1,248 out of 5,508 | 77th |
Major group Chemicals And Allied Products | 505 out of 2,378 | 79th |
Industry group Drugs | 447 out of 2,099 | 79th |
Industry Pharmaceutical Preparations | 307 out of 1,549 | 80th |
Source: SEC filing on April 29, 2022.
Godfrey's colleagues
We found two more compensation records of executives who worked with Wayne Godfrey at Janux Therapeutics in 2021.